RxDoctor Payments Data

Eva Mlynaryk, PA

Physician Assistant · Bronx, NYNPI 1356408918

Payments from drug & device makers

$1,423in general payments, 2019–2025

Across 58 payments — averaging $24.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Progenics Pharmaceuticals, Inc.$171
  • Blue Earth Diagnostics$161
  • Bayer$127
  • Coloplast$116
  • Novartis$91
  • Tolmar, Inc.$85
  • plus $673 from 18 others

What the payments were for

  • Food & beverage$1,423100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,423 in reported general payments places this provider in the 80th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$1,670
Medicare patients
16
Services billed
46

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron94$67,659
GemtesaVibegron19$12,588
Trospium Chloride81$5,375
Solifenacin Succinate66$5,129
Tolterodine Tartrate50$3,465
Fesoterodine Fumarate ErFesoterodine Fumarate16$3,325
Methenamine Hippurate34$3,030
Tolterodine Tartrate ErTolterodine Tartrate25$1,943
Tamsulosin Hcl102$1,444
Finasteride29$365
Oxybutynin Chloride ErOxybutynin Chloride12$242
Alfuzosin Hcl ErAlfuzosin Hcl13$224
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst23$190
Oxybutynin Chloride11$129
Levofloxacin19$59

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$42$67,65994 claims
Sumitomo Pharma America, Inc.Gemtesa$75$12,58819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →